Arbutus Biopharma Corporation

(ABUS) Trade

By |

Profile

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.

Contact Information

Website: www.arbutusbio.com
Email: ir@arbutusbio.com
Main Phone: +1 267 469-0914
Address: 701 Veterans Circle
State: PA
City / Town: Warminster
Country: USA
Postal Code: 18974

Issuer Information

Exchange: NGS
CEO: William H. Collier
Employees: 80
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.

Contact Information

Website: www.arbutusbio.com
Email: ir@arbutusbio.com
Main Phone: +1 267 469-0914
Address: 701 Veterans Circle
State: PA
City / Town: Warminster
Country: USA
Postal Code: 18974

Issuer Information

Exchange: NGS
CEO: William H. Collier
Employees: 80
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 2.05 $ 0.01 (0.49%)
Last Price 2.05 Change $ 0.01 Change % 0.49 Tick N/A
Bid 2.05 Bid Size 100.00 Ask 2.10 Ask Size 200.00
Open 2.03 High 2.15 Low 2.02 Prev Close 2.04
Last Trade Volume 1.2 mi 52 Wk Hi 3.67 52 Wk Low 0.83
Market Cap 141.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 68,961,395.00 EPS (TTM) -2.67 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 4
Number of Buys 1 1
Number of Sells 0 3
Net Activity 27007 -12993
Last 10 Buys Shares
Richard C. Henriques 1,000
Last 10 Sell Shares
Michael J. Sofia 1,000
Michael J. Sofia 1,000
Michael J. Sofia 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 9
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 8.08 8.08 8.08 7.75
Standard Deviation 2.01 2.01 2.01 1.56
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.5